Latest Simvastatin Stories

But some statins can reduce risk of diabetes Treatment with high potency statins (especially atorvastatin and simvastatin) may increase the risk of developing diabetes, suggests a paper published today on bmj.com. Statins are among the most widely prescribed medications for the prevention of cardiovascular events. Although tolerated well, an association with new-onset diabetes has recently been suggested. One trial suggested a 27% increased risk of diabetes with rosuvastatin whereas...

NORTH BRUNSWICK, N.J., May 21, 2013 /PRNewswire/ -- Hurel Corporation ("Hurel"), a world-leading provider of advanced artificial tissue constructs and microfluidic cell-based assay platforms, today announced the appointment of James S. MacDonald, PhD, DABT to the Company's Board of Directors. Dr. MacDonald is the former Executive Vice President of Preclinical Development of the Schering-Plough Research Institute ("SPRI"), which was the pharmaceutical development arm of Schering...

Michael Harper for redOrbit.com – Your Universe Online When looking to decrease cholesterol levels, many doctors prescribe a treatment regimen of diet, exercise and a cholesterol lowering medicine. Researchers from the University of Missouri (Mizzou) have now found that statins, or drugs used to lower cholesterol, may diminish any good done by exercise in obese adults. The researchers looked at one statin in particular, simvastin, better known as “Zocor” in their study. The...

The Firm is currently investigating Zocor lawsuits on behalf of individuals who suffered serious Zocor side effects. New York, New York (PRWEB) April 13, 2013 Bernstein Liebhard LLP notes that a new study is raising additional concerns about possible Zocor side effects, specifically kidney damage. The study, which was published online on March 19 in the British Medical Journal, found that patients treated with higher doses of statins like Zocor were 34% more likely to be hospitalized...

As Medline Plus (a service of the U.S. National Library of Medicine) published on March 20th, 2013, a new study reveals that high potency statins (incl. Zocor) are linked to increased risk for acute kidney injury. In light of these news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Zocor side effects. San Diego, CA (PRWEB) March 29, 2013 AttorneyOne.com, a...

Risk remains elevated for 2 years after initiation Research: Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases Editorial: Statins in acute kidney injury: friend or foe? Patients taking high potency statins for high blood pressure are at a 34% higher risk of being hospitalized for acute kidney injury (AKI), compared with those taking low potency statins, a paper published today on...

HEERLEN, Netherlands and AMSTERDAM, Feb. 14, 2013 /PRNewswire/ -- The Dutch pension fund Stichting Pensioenfonds ABP ("ABP"), together with three co-lead plaintiffs, has reached a settlement with Merck and certain of its current and former officers and directors, whereby Merck will pay $215 million to resolve a five-year-old securities class action against all of the Merck defendants. This settlement is part of a $688 million total settlement that Merck agreed to with plaintiffs in...

NEW YORK, Feb. 14, 2013 /PRNewswire/ -- Today Labaton Sucharow LLP, along with its co-counsel, announced that it reached a $473 million settlement in In re Schering-Plough Corporation / ENHANCE Securities Litigation. The recovery is the largest securities class action settlement ever against a pharmaceutical company, among the top 25 securities class action settlements of all time, and among the ten largest recoveries ever in a securities class action that did not involve a defendant...

OTTAWA, Jan. 24, 2013 /CNW/ - Health Canada is informing Canadians of a labelling update for all cholesterol-lowering drugs (also known as statins) regarding the risk of increased blood sugar levels and a small increased risk of diabetes among patients already at risk for the disease. Based on the review of all available data, Health Canada concluded that the risk of diabetes appears to be mainly in patients with pre-existing risk factors for diabetes, such as high levels of...

Up to 75 per cent of patients who take statins to treat elevated cholesterol levels may suffer from muscle pain. Scientists at the Center for Healthy Aging at the University of Copenhagen have now identified a possible mechanism underlying this unfortunate side effect. The results have just been published in the well-reputed Journal of American College of Cardiology. Statin is a class of drugs which are used to treat high levels of blood cholesterol by way of inhibiting the liver’s...